Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. The four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative solutions and services in more than 100 countries.


As pioneers in the field of the plasma science, it is one of the largest plasma companies with a growing network of donation centers worldwide. Grifols develops this plasma into essential medicines used to treat rare, chronic and, at times, life-threatening conditions. As a recognized leader in transfusion medicine, it also offers a comprehensive portfolio of solutions designed to enhance safety from donation through transfusion.  It continues to advance its legacy of innovation by supplying tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care.


Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry.